Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Parkinson's Disease

Free Subscription 22.06.2026 1 Ann Neurol 2 BMC Neurol 5 J Neural Transm (Vienna) 1 J Neurol Neurosurg Psychiatry 2 Lancet Neurol 6 Mov Disord 2 Nat Med 1 Nat Ment Health 1 Neurol Genet 4 Neurology 1 Neurosci Lett 1 Neuroscience 1 PLoS One 1 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. KRYZE P, Sousa M, Illner V, Jorge A, et al
   Speech Biomarkers for Quantifying Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease.
   Ann Neurol. 2026 Jun 14. doi: 10.1002/ana.78276.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. HONG R, Wu Z, Zhu S, Pan L, et al
   Efficacy and safety of (99m)Tc-MIBI SPECT-guided botulinum toxin injection in parkinsonian postural abnormality.
   BMC Neurol. 2026 Jun 17. doi: 10.1186/s12883-026-05072.
   PubMed         Abstract available
   
   
3. CHEN YS, Chen CM, Juan CH, Cheng ML, et al
   Sex-specific differences and diagnostic tool performance in the neuropsychiatric profile of Parkinson's disease.
   BMC Neurol. 2026 Jun 15. doi: 10.1186/s12883-026-05056.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

4. GROPPA S, Fasano A, Urso D, Yang X, et al
   Disease modification in advanced Parkinson's disease: a review and roadmap for paving the way for next-generation interventions.
   J Neural Transm (Vienna). 2026 Jun 19. doi: 10.1007/s00702-026-03208.
   PubMed         Abstract available
   
   
5. REICHMANN H
   Why dopamine replacement therapy will stay as a cornerstone in the treatment of Parkinson disease: a personal opinion.
   J Neural Transm (Vienna). 2026 Jun 18. doi: 10.1007/s00702-026-03205.
   PubMed         Abstract available
   
   
6. HESTON A, Askari A, Wyant K, Patil PG, et al
   Active electrode location does not influence weight gain after subthalamic nucleus deep brain stimulation surgery in Parkinson disease.
   J Neural Transm (Vienna). 2026 Jun 13. doi: 10.1007/s00702-026-03201.
   PubMed         Abstract available
   
   
7. STORCH A, Wendel V, Lohle M, Odin P, et al
   Non-motor fluctuation patterns in dyskinetic patients with advanced Parkinson's disease.
   J Neural Transm (Vienna). 2026 Jun 13. doi: 10.1007/s00702-026-03188.
   PubMed         Abstract available
   
   
8. L ROSALES R, M Doquenia ML, D Delos Santos MM, J Tanglao M, et al
   Clinical outcomes and safety of botulinum toxin injections for X-linked dystonia parkinsonism: a five-year experience from a tertiary center in the Philippines.
   J Neural Transm (Vienna). 2026 Jun 13. doi: 10.1007/s00702-026-03191.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

9. IVESON MH, Mukherjee M, Davidson EM, Zhang H, et al
   Clinically reported covert cerebrovascular disease and risk of neurological disease: a whole-population cohort of 367 988 people using natural language processing.
   J Neurol Neurosurg Psychiatry. 2026 Mar 13:jnnp-2025-337689.
   PubMed         Abstract available
   
   

   
   Lancet Neurol

10. DALVI A, Eisenberg HM, Wu P, Zucker L, et al
    Safety and efficacy of staged, bilateral magnetic resonance-guided focused ultrasound pallidothalamic tractotomy for motor complications of Parkinson's disease: a prospective, multicentre, single-arm trial.
    Lancet Neurol. 2026;25:654-663.
    PubMed         Abstract available
    
    
11. ZRINZO L
    Unilateral promise and bilateral caution in focused ultrasound for Parkinson's disease.
    Lancet Neurol. 2026;25:619-621.
    PubMed        
    
    

    
    Mov Disord

12. CORCOS DM, Munoz MJ, Mehta N, McKee KE, et al
    Physical Activity and Exercise for People with Parkinson's Disease: The Past, Present, and Future.
    Mov Disord. 2026 Jun 14. doi: 10.1002/mds.70396.
    PubMed         Abstract available
    
    
13. SUBRAMANIAN I, Rusch C
    When the Scale Drops: Pathways to Weight Loss in Parkinson's Disease and Future Directions.
    Mov Disord. 2026 Jun 15. doi: 10.1002/mds.70385.
    PubMed        
    
    
14. FIORENZATO E, Cauzzo S, Musso G, Biundo R, et al
    Plasma p-tau217 Versus p-tau181 in Parkinson's Disease: Differential Associations with Alzheimer's Disease-Related Neurostructural Changes and Cognitive Function.
    Mov Disord. 2026 Jun 15. doi: 10.1002/mds.70392.
    PubMed         Abstract available
    
    
15. TAMBASCO N, Nigro P
    Idebenone in Rapid Eye Movement Sleep Behavioral Disorder for Parkinson's Disease Prevention.
    Mov Disord. 2026 Jun 15. doi: 10.1002/mds.70409.
    PubMed        
    
    
16. LI Y, Liu J
    Reply to: "Idebenone in Rapid Eye Movement Sleep Behavioral Disorder for Parkinson's Disease Prevention".
    Mov Disord. 2026 Jun 15. doi: 10.1002/mds.70408.
    PubMed        
    
    
17. KOEGLSPERGER T, Scherer M, Kuhn AA, Eusebio A, et al
    Authors' Comments on "Adaptive Deep Brain Stimulation for Parkinson's Disease: Navigating the Roadblocks to Clinical Implementation".
    Mov Disord. 2026 Jun 17. doi: 10.1002/mds.70406.
    PubMed        
    
    

    
    Nat Med

18. LOUIE KH, Balakid JP, Bath JE, Song S, et al
    Adaptive deep brain stimulation for dynamic gait control in Parkinson's disease: a randomized feasibility trial.
    Nat Med. 2026 Jun 15. doi: 10.1038/s41591-026-04434.
    PubMed         Abstract available
    
    
19. SCAFA S, de Seta V, Wang R, Sanchez Lopez P, et al
    Activity-dependent adaptive deep brain stimulation improves gait in Parkinson's disease.
    Nat Med. 2026 Jun 15. doi: 10.1038/s41591-026-04432.
    PubMed         Abstract available
    
    

    
    Nat Ment Health

20. VIGNANDO M, Ffytche D, Mazibuko N, Palma G, et al
    Deviations in effective connectivity explain different hallucination subtypes in Parkinson's disease psychosis.
    Nat Ment Health. 2026;4:994-1009.
    PubMed         Abstract available
    
    

    
    Neurol Genet

21. ISHIGURO M, Funayama M, Park DH, Hatano T, et al
    Expanding the Spectrum of BCAP31-Associated Diseases: Early-Onset Parkinson Disease.
    Neurol Genet. 2026;12:e200404.
    PubMed         Abstract available
    
    

    
    Neurology

22. PELTZ C, Albrecht J, Bahorik AL, Xia F, et al
    Neurologic Diagnoses Before and After Traumatic Brain Injury: A Retrospective Cohort Study of Older Veterans.
    Neurology. 2026;107:e218214.
    PubMed         Abstract available
    
    
23. BOEVE BF, Nie Y, Lu R, De La Cruz H, et al
    The Prodromal Synucleinopathy Rating Scale: An Assessment in Patients With REM Sleep Behavior Disorder.
    Neurology. 2026;107:e218176.
    PubMed         Abstract available
    
    
24. PEREIRA MAOM, Tudella GCN, Klostermann AU, Ohannesian VA, et al
    Fecal Microbiota Transplantation in Parkinson Disease: A Systematic Review, Meta-Analysis, and Meta-Regression.
    Neurology. 2026;107:e218175.
    PubMed         Abstract available
    
    
25. ZAFER SYED M, Fasano A
    Re-Emergent Tongue Tremor in Parkinson Disease.
    Neurology. 2026;107:e218219.
    PubMed        
    
    

    
    Neurosci Lett

26. ZHANG X, Li W, Hu Y, Yu Y, et al
    Data-driven clustering of prefrontal activation identifies functional phenotypes under prioritized dual-task walking conditions in Parkinson's disease.
    Neurosci Lett. 2026 Jun 18:138663. doi: 10.1016/j.neulet.2026.138663.
    PubMed         Abstract available
    
    

    
    Neuroscience

27. TANIGUCHI S, Dijkstra BW, D'cruz N, Nieuwboer A, et al
    Task-dependent changes in effective connectivity from limbic to cognitive networks during motor imagery of freezing of gait in Parkinson's disease.
    Neuroscience. 2026 Jun 15:S0306-4522(26)00390.
    PubMed         Abstract available
    
    

    
    PLoS One

28. BOSCH-BARCELO P, Climent-Sanz C, Martinez-Navarro O, Masbernat-Almenara M, et al
    Correction: A treadmill training program in a gamified virtual reality environment combined with transcranial direct current stimulation in Parkinson's Disease: Study protocol for a randomized controlled trial.
    PLoS One. 2026;21:e0352097.
    PubMed         Abstract available
    
    

    
    Rev Neurol (Paris)

29. MARQUES A, Lambert C, Derost P, Beal C, et al
    Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?
    Rev Neurol (Paris). 2026 Jun 17:S0035-3787(26)00552.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum